MicroRNA-138 negatively regulates non-small cell lung cancer cells through the interaction with cyclin D3
Authors:
- 23 July 2015
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 37 (1) , 291-298
Abstract
Previous studies demonstrate that microRNA-138 (miR-138) is critical in non-small cell lung cancer (NSCLC) regulation. We further explored the molecular mechanism of miR-138 in NSCLC. Lentivirus was used to upregulate miR-138 in NSCLC cell lines H460 and SPC-A1 cells. Previously known effects of miR-138 upregulation on NSCLC, proliferation, cell cycle division, and cisplatin sensitivity were examined in H460 and SPC-A1 cells. Moreover, previously unknown effect of miR-138 upregulation on NSCLC migration was also examined in H460 and SPC-A1 cells. A new miR-138 downstream target, cyclin D3 (CCND3), was assessed by dual-luciferase reporter assay and quantitative real-time PCR (qRT-PCR). CCND3 was then ectopically overexpressed in H460 and SPC-A1 cells. The effects of forced overexpression of CCND3 on miR-138-induced NSCLC regulations were further examined by proliferation, cell cycle, cisplatin sensitivity, and migration assays, respectively. Lentivirus-induced miR-138 upregulation inhibited NSCLC proliferation and cell cycle division, in line with previous findings. Moreover, we found that miR-138 upregulation had other anti-tumor effects, such as increasing cisplatin sensitivity and reducing cancer migration, in H460 and SPC-A1 cells. Luciferase assay and qRT-PCR showed that CCND3 was directly targeted by miR-138. Forced overexpression of CCND3 in H460 and SPC-A1 cells reversed the anti-tumor effects of miR-138 upregulation on cancer cell growth, cell cycle, cisplatin sensitivity, and migration. Our study revealed novel anti-cancer effects of miR-138 upregulation in NSCLC, as well as its new molecular target of CCND3.Keywords
This publication has 21 references indexed in Scilit:
- MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung CancerCellular Physiology and Biochemistry, 2013
- MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinomaCarcinogenesis, 2012
- MicroRNA-138 Modulates DNA Damage Response by Repressing Histone H2AX ExpressionMolecular Cancer Research, 2011
- MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cellsNucleic Acids Research, 2011
- miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent mannerMolecular Cancer, 2011
- Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumorsInternational Journal of Cancer, 2009
- Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathwayCarcinogenesis, 2008
- Involvement of cyclin D3 in liver metastasis of colorectal cancer, revealed by genome-wide copy-number analysisLaboratory Investigation, 2005
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994